Angela M. Cacace - Feb 24, 2025 Form 4 Insider Report for ARVINAS, INC. (ARVN)

Role
Chief Scientific Officer
Signature
/s/ Jared Freedberg, as attorney-in-fact for Angela M. Cacace
Stock symbol
ARVN
Transactions as of
Feb 24, 2025
Transactions value $
-$70,238
Form type
4
Date filed
2/25/2025, 06:35 AM
Previous filing
Feb 18, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARVN Common Stock Sale -$51.3K -3.06K -3.02% $16.75 98.4K Feb 24, 2025 Direct F1, F2
transaction ARVN Common Stock Sale -$19K -1.15K -1.16% $16.55 97.2K Feb 24, 2025 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-half of the reporting person's restricted stock units (RSUs) granted on February 23, 2024.
F2 Includes an aggregate of 494 shares of the issuer's common stock purchased under and in accordance with the issuer's 2018 Employee Stock Purchaser Plan in transactions exempt under Rule 16b-3.
F3 This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-quarter of the reporting person's RSUs granted on February 22, 2023.